Thompson Siegel & Walmsley’s Coherus Oncology CHRS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-10,070	Closed	-$97K	–	559
2022 Q3	$97K	Buy	10,070 +854	+9%	+$8.64K	﹤0.01%	390
2022 Q2	$67K	Sell	9,216 -696,440	-99%	-$6.06M	﹤0.01%	400
2022 Q1	$9.11M	Buy	705,656 +147,193	+26%	+$1.87M	0.13%	163
2021 Q4	$8.91M	Sell	558,463 -43,908	-7%	-$768K	0.12%	160
2021 Q3	$9.68M	Sell	602,371 -207,042	-26%	-$3.03M	0.14%	148
2021 Q2	$11.2M	Buy	809,413 +144,850	+22%	+$2.05M	0.15%	131
2021 Q1	$9.71M	Buy	664,563 +152,710	+30%	+$2.59M	0.14%	138
2020 Q4	$8.9M	Buy	511,853 +137,168	+37%	+$2.44M	0.14%	140
2020 Q3	$6.87M	Sell	374,685 -58,532	-14%	-$1.09M	0.13%	142
2020 Q2	$7.74M	Buy	+433,217	New	+$7.33M	0.16%	127